{"id":"NCT01385202","sponsor":"Biosense Webster, Inc.","briefTitle":"THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation","officialTitle":"THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-06","primaryCompletion":"2013-02","completion":"2013-05","firstPosted":"2011-06-30","resultsPosted":"2015-01-26","lastUpdate":"2025-02-04"},"enrollment":172,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Heart Diseases","Arrhythmia","Atrial Fibrillation"],"interventions":[{"type":"DEVICE","name":"THERMOCOOL® SMARTTOUCH™ Catheter","otherNames":[]}],"arms":[{"label":"THERMOCOOL® SMARTTOUCH™ Catheter","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheters with Contact Force Sensing Capability in the treatment of drug refractory symptomatic paroxysmal Atrial Fibrillation (AF) during standard electrophysiology mapping and RF procedures.","primaryOutcome":{"measure":"The Rate of Subjects Who Were Free From Documented Symptomatic Atrial Fibrillation (AF), Atrial Tachycardia (AT), or Atrial Flutter (AFL) Episodes Through 12-month Follow-up","timeFrame":"12-months","effectByArm":[{"arm":"THERMOCOOL® SMARTTOUCH™ Catheter","deltaMin":70.2,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.0001"},{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["29759747","25125294"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":161},"commonTop":["SHORTNESS OF BREATH","ATRIAL FIBRILLATION RECURRENCE","ATRIAL FLUTTER","HOSPITALIZATION, INTIAL AND PROLONGED","HYPOTENSION"]}}